Skip to main content

stock

ALT · Altimmune, Inc.

What Altimmune, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ALT price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ALT.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
194,517,701 as of 2026-08-07 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-19.4%
ROA
-17.4%

Health

Current ratio
26.8x
Debt/equity
0.1x

Deep value

NCAV
$281.81M
NCAV per share
$1.45
Price/NCAV
Locked
NNWC
$10.00M
NNWC per share
$0.05
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$26.23M-$22.82M
10-Q filed 2026-08-12
2026-03-31——Gross profit: unreported by this company.-$24.24M-$22.56M
10-Q filed 2026-08-12
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$26,000—Gross profit: unreported by this company.-$28.89M-$27.36M
10-K filed 2026-03-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$5,000—Gross profit: unreported by this company.-$20.86M-$19.01M
10-Q filed 2025-11-06
2025-06-30$5,000—Gross profit: unreported by this company.-$22.92M-$22.15M
10-Q filed 2026-08-12
2025-03-31$5,000—Gross profit: unreported by this company.-$21.82M-$19.57M
10-Q filed 2026-08-12
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$5,000—Gross profit: unreported by this company.-$24.87M-$23.18M
10-K filed 2026-03-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$5,000—Gross profit: unreported by this company.-$24.77M-$22.84M
10-Q filed 2025-11-06
Assets
$527.21M
Equity
$474.21M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$41,000-$94.49M-$88.09M-$67.55M
2024-12-31$20,000-$103.17M-$95.06M—
2023-12-31$426,000-$95.93M-$88.45M-$75.86M
2022-12-31-$68,000-$87.74M-$84.71M-$62.71M
2021-12-31$4.41M-$96.91M-$97.09M-$90.36M
2020-12-31$8.19M-$54.80M-$49.04M-$34.51M
2019-12-31$5.80M-$21.46M-$20.52M-$9.60M
2018-12-31$10.33M-$42.83M-$39.17M-$10.36M
2017-12-31$10.74M-$52.05M-$46.43M-$20.33M
2016-12-31$3.24M-$11.09M-$11.09M—

Company filings

since Thu Nov 13 · 4 offering filings in 12 months · since Wed Jan 28

events

  • Executive or director change

    Executive or director change
    Sep 298-K
  • Results

    Results
    Aug 128-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Jul 288-K
  • Other event

    Other event
    Jun 168-K
  • Results

    Results
    May 138-K
  • Material agreement

    Material agreement
    Apr 248-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Durso Jerome Benedict

    President and CEO, Director

    Buy$44,250

    Aug 13, 4:05 PM ET

All insider trades for ALT

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

All funds

News

Stories that named ALT, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ALT.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ALT.

nakagai

Signals on ALT come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ALT board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Altimmune, Inc. (ALT): SEC filings, financials and insider trades · Nakagai